Alta Partners Management Company, L.P. Vir Biotechnology, Inc. Transaction History
Alta Partners Management Company, L.P.
- $63.4 Billion
- Q4 2024
A detailed history of Alta Partners Management Company, L.P. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Alta Partners Management Company, L.P. holds 489,485 shares of VIR stock, worth $4.92 Million. This represents 5.67% of its overall portfolio holdings.
Number of Shares
489,485Holding current value
$4.92 Million% of portfolio
5.67%Shares
1 transactions
Others Institutions Holding VIR
# of Institutions
215Shares Held
85.7MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$168 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$165 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$132 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$56.5 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$35.9 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.33B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...